Dimensional Fund Advisors LP Sells 30,139 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Dimensional Fund Advisors LP trimmed its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRAFree Report) by 0.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,345,736 shares of the real estate investment trust’s stock after selling 30,139 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Sabra Health Care REIT were worth $57,946,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. VSM Wealth Advisory LLC bought a new stake in shares of Sabra Health Care REIT in the fourth quarter worth $26,000. Assetmark Inc. grew its position in shares of Sabra Health Care REIT by 33.4% in the 4th quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust’s stock valued at $45,000 after buying an additional 656 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of Sabra Health Care REIT in the third quarter valued at about $59,000. Jones Financial Companies Lllp raised its position in shares of Sabra Health Care REIT by 208.3% during the fourth quarter. Jones Financial Companies Lllp now owns 6,222 shares of the real estate investment trust’s stock worth $108,000 after acquiring an additional 4,204 shares during the last quarter. Finally, FIL Ltd lifted its stake in shares of Sabra Health Care REIT by 40.4% in the fourth quarter. FIL Ltd now owns 6,512 shares of the real estate investment trust’s stock worth $113,000 after acquiring an additional 1,873 shares during the period. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Health Care REIT Stock Performance

NASDAQ:SBRA opened at $17.62 on Friday. The firm has a market capitalization of $4.19 billion, a P/E ratio of 33.25, a P/E/G ratio of 1.97 and a beta of 0.93. Sabra Health Care REIT, Inc. has a twelve month low of $13.87 and a twelve month high of $20.03. The company has a fifty day moving average of $17.25 and a 200-day moving average of $17.51. The company has a quick ratio of 4.16, a current ratio of 4.32 and a debt-to-equity ratio of 0.88.

Sabra Health Care REIT (NASDAQ:SBRAGet Free Report) last announced its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share for the quarter, meeting the consensus estimate of $0.36. The firm had revenue of $182.35 million for the quarter, compared to analyst estimates of $178.01 million. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. As a group, sell-side analysts anticipate that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current year.

Sabra Health Care REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were paid a $0.30 dividend. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a yield of 6.81%. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 226.42%.

Analyst Upgrades and Downgrades

SBRA has been the subject of a number of recent analyst reports. JMP Securities raised shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 target price for the company in a research report on Tuesday, January 7th. Truist Financial increased their price objective on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Tuesday, March 18th. Finally, Citizens Jmp upgraded shares of Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 7th. Three equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Sabra Health Care REIT currently has an average rating of “Moderate Buy” and a consensus target price of $19.33.

Read Our Latest Stock Analysis on SBRA

Sabra Health Care REIT Company Profile

(Free Report)

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.

Recommended Stories

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Health Care REIT, Inc. (NASDAQ:SBRAFree Report).

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.